These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 33103545
1. Efficacy and Safety of ProGlide Versus Prostar XL Vascular Closure Devices in Transcatheter Aortic Valve Replacement: The RISPEVA Registry. Berti S, Bedogni F, Giordano A, Petronio AS, Iadanza A, Bartorelli AL, Reimers B, Spaccarotella C, Trani C, Attisano T, Marella Cenname A, Sardella G, Bonmassari R, Medda M, Tomai F, Tarantini G, Navarese EP, Italian Society of Interventional Cardiology‐GISE†. J Am Heart Assoc; 2020 Nov 03; 9(21):e018042. PubMed ID: 33103545 [Abstract] [Full Text] [Related]
3. A systematic review on the safety of Prostar XL versus ProGlide after TAVR and EVAR. Maniotis C, Andreou C, Karalis I, Koutouzi G, Agelaki M, Koutouzis M. Cardiovasc Revasc Med; 2017 Mar 03; 18(2):145-150. PubMed ID: 27887905 [Abstract] [Full Text] [Related]
4. Impact of suture mediated femoral access site closure with the Prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation. Seeger J, Gonska B, Rodewald C, Rottbauer W, Wöhrle J. Int J Cardiol; 2016 Nov 15; 223():564-567. PubMed ID: 27561160 [Abstract] [Full Text] [Related]
5. Comparison of ProGlide vs. Prostar in patients undergoing transcatheter aortic valve implantation. Giordano A, Corcione N, Ferraro P, Morello A, Conte S, Testa L, Iadanza A, Sardella G, Mancone M, Berti S, Petronio AS, Romagnoli E, Pepe M, Frati G, Biondi-Zoccai G, Registro Italiano GISE sull'impianto di Valvola Aortica Percutanea (RISPEVA) Study Investigators. Minerva Cardioangiol; 2019 Dec 15; 67(6):443-449. PubMed ID: 31670491 [Abstract] [Full Text] [Related]
6. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation. Lareyre F, Raffort J, Dommerc C, Benhammamia M, Bourlon F, Habib Y, Mialhe C. Vasc Endovascular Surg; 2017 Jul 15; 51(5):282-287. PubMed ID: 28474978 [Abstract] [Full Text] [Related]
7. One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation. Mehilli J, Jochheim D, Abdel-Wahab M, Rizas KD, Theiss H, Spenkuch N, Zadrozny M, Baquet M, El-Mawardy M, Sato T, Lange P, Kuppatt C, Greif M, Hausleiter J, Bauer A, Schwarz F, Pichlmaier M, Hagl C, Richardt G, Massberg S. EuroIntervention; 2016 Nov 20; 12(10):1298-1304. PubMed ID: 27866140 [Abstract] [Full Text] [Related]
8. Vascular complications of ProGlide versus Prostar in transcatheter aortic valve replacement (TAVR) procedures: meta-analysis. Xiang Y, Chen C, Zhao J, Ma Y, Huang B, Wu Z. BJS Open; 2023 Jul 10; 7(4):. PubMed ID: 37498966 [Abstract] [Full Text] [Related]
9. Outcomes with plug-based versus suture-based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta-analysis. Sedhom R, Dang AT, Elwagdy A, Megaly M, Elgendy IY, Zahr F, Gafoor S, Mamas M, Elbadawi A. Catheter Cardiovasc Interv; 2023 Mar 10; 101(4):817-827. PubMed ID: 36802100 [Abstract] [Full Text] [Related]
12. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry. Kodama A, Yamamoto M, Shimura T, Kagase A, Koyama Y, Tada N, Takagi K, Araki M, Yamanaka F, Shirai S, Watanabe Y, Hayashida K. Catheter Cardiovasc Interv; 2017 Sep 01; 90(3):E55-E62. PubMed ID: 27785881 [Abstract] [Full Text] [Related]
13. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure. Saleh N, De Palma R, Settergren M, Rück A. Catheter Cardiovasc Interv; 2015 Dec 01; 86(7):1255-61. PubMed ID: 26332528 [Abstract] [Full Text] [Related]
14. Impact of closure devices on vascular complication and mortality rates in TAVI procedures. Dimitriadis Z, Scholtz W, Börgermann J, Wiemer M, Piper C, Vlachojannis M, Gummert J, Horstkotte D, Ensminger S, Faber L, Scholtz S. Int J Cardiol; 2017 Aug 15; 241():133-137. PubMed ID: 28153535 [Abstract] [Full Text] [Related]
15. Vascular Complications Among Patients Undergoing Trans-femoral Transcatheter Aortic Valve Implantation: Prostar vs ProGlide Parallel Technique. Marcusohn E, Qasum M, Epstein D, Solomonica A, Orbach A, Musallam A, Kerner A, Feld Y. Angiology; 2022 Aug 15; 73(7):635-642. PubMed ID: 35147041 [Abstract] [Full Text] [Related]
16. Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial. Power D, Schäfer U, Guedeney P, Claessen BE, Sartori S, Sorrentino S, Lefèvre T, Kupatt C, Tchetche D, Dumonteil N, Webb JG, Colombo A, Windecker S, Ten Berg JM, Hildick-Smith D, Boekstegers P, Linke A, Tron C, Van Belle E, Asgar AW, Jeger R, Sardella G, Hink U, Husser O, Grube E, Lechthaler I, Wijngaard P, Anthopoulos P, Deliargyris EN, Bernstein D, Hengstenberg C, Mehran R, Dangas GD. Catheter Cardiovasc Interv; 2019 Jun 01; 93(7):1374-1381. PubMed ID: 31116908 [Abstract] [Full Text] [Related]
17. The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center. Bazarbashi N, Ahuja K, Gad MM, Sammour YM, Kaur M, Karrthik A, Saad AM, Khubber S, Dhaliwal K, Mick SL, Navia JL, Puri R, Reed GW, Krishnaswamy A, Kapadia SR. Catheter Cardiovasc Interv; 2020 Aug 01; 96(2):442-447. PubMed ID: 31713996 [Abstract] [Full Text] [Related]